Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-259637

President and CEO bought 250,000 shares at $1.67 ($418,450)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brady Todd C President and CEO 2026-06-03 Purchase +250,000 $1.67 $418,450 1,721,298 D
Open-market purchases · 250,000 sh · avg $1.67 · $418,450
Loading xslF345X06/ownership.xml…